{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:57:22Z","timestamp":1774882642417,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,3,22]],"date-time":"2020-03-22T00:00:00Z","timestamp":1584835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,22]],"date-time":"2020-03-22T00:00:00Z","timestamp":1584835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10157-020-01875-y","type":"journal-article","created":{"date-parts":[[2020,3,22]],"date-time":"2020-03-22T16:02:30Z","timestamp":1584892950000},"page":"622-629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome"],"prefix":"10.1007","volume":"24","author":[{"given":"Biswanath","family":"Basu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shilpita","family":"Barua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhisek","family":"Naskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birendranath","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,22]]},"reference":[{"key":"1875_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0022-3476(79)80658-7","volume":"95","author":"HL Barnett","year":"1979","unstructured":"Barnett HL. Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children. J Pediatr. 1979;95:228\u201333.","journal-title":"J Pediatr"},{"key":"1875_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1542\/pir.30-3-94","volume":"30","author":"R Gordillo","year":"2009","unstructured":"Gordillo R, Spitzer A. The nephrotic syndrome. Pediatr Rev. 2009;30:94.","journal-title":"Pediatr Rev"},{"key":"1875_CR3","unstructured":"Consensus Statement of Management of Steroid Sensitive Nephrotic Syndrome. Indian Pediatric Nephrology Group, Indian Academy of Pediatrics. Indian Pediatr 2008;45:203\u201314."},{"issue":"10","key":"1875_CR4","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2215\/CJN.05950809","volume":"4","author":"P Niaudet","year":"2009","unstructured":"Niaudet P. long term outcome of children with steroid sensitive idiopathic nephrotic syndrome. CJASN. 2009;4(10):1547\u20138.","journal-title":"CJASN"},{"key":"1875_CR5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s00467-008-1089-2","volume":"24","author":"J Feber","year":"2009","unstructured":"Feber J, Al-Matrafi J, Farhadi E, et al. Prednisone dosing per body weight or body surface area in children with nephrotic syndrome\u2014is it equivalent? Pediatr Nephrol. 2009;24:1027\u201331.","journal-title":"Pediatr Nephrol"},{"key":"1875_CR6","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1007\/s00467-011-1961-3","volume":"26","author":"SA Saadeh","year":"2011","unstructured":"Saadeh SA, Baracco R, Jain A, et al. Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference? Pediatr Nephrol. 2011;26:2167\u201371.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"1875_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00467-015-3285-1","volume":"31","author":"V Raman","year":"2016","unstructured":"Raman V, Krisnamurthy S, Harichandrakumar K. Body weight based prednisolone versus surface area based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open label, equivalence clinical trial. Pediatr Nephrol. 2016;31(4):595\u2013604.","journal-title":"Pediatr Nephrol"},{"key":"1875_CR8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1046\/j.1523-1755.2000.00279.x","volume":"58","author":"M Hiraoka","year":"2000","unstructured":"Hiraoka M, Tsukahara H, Haruki S, et al. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of kidney disease in Children. Kidney Int. 2000;58:1247\u201352.","journal-title":"Kidney Int."},{"key":"1875_CR9","first-page":"C72","volume":"19","author":"C Pecoraro","year":"2004","unstructured":"Pecoraro C, Caropreso MR, Passaro G, et al. Therapy of first episode of steroid responsive nephrotic syndrome: a randomized controlled trial [abstract]. Pediatr Nephrol. 2004;19:C72.","journal-title":"Pediatr Nephrol"},{"key":"1875_CR10","first-page":"1098","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD. Simplified calculation of body-surface area. N Engl J Med. 1987;317:1098.","journal-title":"N Engl J Med"},{"key":"1875_CR11","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140:e20171904.","journal-title":"Pediatrics"},{"key":"1875_CR12","unstructured":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE). Publish Date: 9 Aug 2006"},{"key":"1875_CR13","unstructured":"Kidney Disease: improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2012;2:739\u2013774"},{"key":"1875_CR14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol. 1997;8:769\u201376.","journal-title":"J Am Soc Nephrol"},{"key":"1875_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1055\/s-2008-1033800","volume":"194","author":"J Brodehl","year":"1982","unstructured":"Brodehl J, Krohn HP, Ehrich JH. The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft fur PadiatrischeNephrologie (APN). Klin Padiatr. 1982;194:162\u20135.","journal-title":"Klin Padiatr"},{"key":"1875_CR16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF01956754","volume":"152","author":"JH Ehrich","year":"1993","unstructured":"Ehrich JH, Brodehl J. Long versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children Arbeitsgemeinschaft fur PadiatrischeNephrologie. Eur J Pediatr. 1993;152:357\u201361.","journal-title":"Eur J Pediatr"},{"key":"1875_CR17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s004670050708","volume":"13","author":"A Bagga","year":"1999","unstructured":"Bagga A, Hari P, Srivastava RN. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome. Pediatr Nephrol. 1999;13:824\u20137.","journal-title":"Pediatr Nephrol"},{"key":"1875_CR18","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1651-2227.1995.tb13787.x","volume":"84","author":"J Ksiazek","year":"1995","unstructured":"Ksiazek J, Wyszynska T. Short versus long initial prednisone treatment in steroid-sensitive nephrotic syndrome in children. Acta Paediatr. 1995;84:889\u201393.","journal-title":"Acta Paediatr"},{"key":"1875_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s13312-012-0220-4","volume":"49","author":"A Sinha","year":"2012","unstructured":"Sinha A, Hari P, Sharma PK, et al. Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr. 2012;49:881\u20137.","journal-title":"Indian Pediatr"},{"key":"1875_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s004670050489","volume":"12","author":"N Kabuki","year":"1998","unstructured":"Kabuki N, Okugawa T, Hayakawa H, et al. Influence of age at onset on the outcome of steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 1998;12:467\u201370.","journal-title":"Pediatr Nephrol"},{"key":"1875_CR21","first-page":"CD002290","volume":"23","author":"EM Hodson","year":"2008","unstructured":"Hodson EM, Willis NS, Craig JC. Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst Rev. 2008;23:CD002290.","journal-title":"Cochrane Database Syst Rev."},{"key":"1875_CR22","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00467-011-1993-8","volume":"26","author":"O Mehls","year":"2011","unstructured":"Mehls O, Hoyer PF. Dosing of glucocorticosteroids in nephrotic syndrome. Pediatr Nephrol. 2011;26:2095\u20138.","journal-title":"Pediatr Nephrol"},{"key":"1875_CR23","first-page":"CD001533","volume":"3","author":"D Hahn","year":"2015","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC. Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev. 2015;3:CD001533.","journal-title":"Cochrane Database Syst Rev"},{"key":"1875_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ki.2014.260","volume":"87","author":"N Yoshikawa","year":"2015","unstructured":"Yoshikawa N, Nakanishi K, Sako M, et al. Japanese Study Group of Kidney Disease in Children. A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for 2 months is not inferior to 6-month treatment. Kidney Int. 2015;87:225\u201332.","journal-title":"Kidney Int"},{"key":"1875_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ki.2014.240","volume":"87","author":"A Sinha","year":"2015","unstructured":"Sinha A, Saha A, Kumar M, et al. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int. 2015;87:217\u201324.","journal-title":"Kidney Int"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-020-01875-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-020-01875-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-020-01875-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T12:38:07Z","timestamp":1666183087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-020-01875-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,22]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1875"],"URL":"https:\/\/doi.org\/10.1007\/s10157-020-01875-y","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,22]]},"assertion":[{"value":"15 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have indicated they have no potential conflicts of interest to disclose. This research involved Human Participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from the parents after provision of detailed oral and written information concerning the context of the study, potential benefit to the child and comprehensive safety aspects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}